ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 21 Issue : 3
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
What is better for predilatation in bioresorbable vascular scaffold implantation: a non-compliant or a compliant balloon? [Anatol J Cardiol]
Anatol J Cardiol. 2016; 16(4): 244-249 | DOI: 10.5152/AnatolJCardiol.2015.6184  

What is better for predilatation in bioresorbable vascular scaffold implantation: a non-compliant or a compliant balloon?

Erdem Özel, Ahmet Taştan, Ali Öztürk, Emin Evren Özcan, Samet Uyar, Ömer Şenarslan
Department Of Cardiology, Şifa University, İzmir- Turkey

Objective: The bioresorbable vascular scaffold system (BVS) is a fully absorbable vascular treatment system. In this study, we aimed to compare the periprocedural effectiveness and long term results of non-compliant balloon (NCB) and compliant balloon (CB) systems, which are used for predilatation before BVS implantation.
Methods: One hundred forty-six BVS-treated lesions from 119 patients were retrospectively analyzed in the study. Patients with acute coronary syndrome, stable angina and silent ischemia were included in the study. Lesions and patients were categorized into the NCB and CB groups according to the type of balloon used for predilatation. NCB was implemented on 72 lesions (59 patients) and CB was implemented on 74 lesions (60 patients). The two groups were compared on terms of procedural features and both in-hospital and 1-year clinical follow-up results. Chisquare and independent sample t test were performed for statistical analysis.
Results: There was no significant difference between the two groups in terms of patient characteristics and lesion properties. The number of postdilated lesions was significantly higher in the CB group. Procedure time, fluoroscopy time, and contrast volume were significantly lower in the NCB group. At follow-up, one patient had myocardial infarction in the CB group because of scaffold thrombosis and no mortality was observed.
Conclusion: Predilatation with NCB before BVS implantation reduces the need for postdilatation. In addition, use of NCB reduces the procedure time, fluoroscopy time, and contrast volume but had no effect on 1 year clinical follow-up results compared with CB. (Anatol J Cardiol 2016; 16: 244-9)

Keywords: bioresorbable vascular scaffold, predilatation, non-compliant balloon, compliant balloon


Erdem Özel, Ahmet Taştan, Ali Öztürk, Emin Evren Özcan, Samet Uyar, Ömer Şenarslan. What is better for predilatation in bioresorbable vascular scaffold implantation: a non-compliant or a compliant balloon?. Anatol J Cardiol. 2016; 16(4): 244-249

Corresponding Author: Erdem Özel, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology